President Donald Trump on Monday reiterated his plans to impose levies in the “not too distant future” against pharmaceutical ...

WASHINGTON (Reuters) -U.S. President Donald Trump said on Monday that he expects to impose tariffs on imported ...

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

While Trump has been wildly inconsistent on his plans for reciprocal tariffs, levies on imported pharmaceuticals appear to be ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

After exploring a rival buyout offer worth 50% more than its first, bluebird bio is back where it started. | After striking ...

Indian pharma firms eye full exemption from US reciprocal tariffs amid a 90-day breather, citing America's heavy reliance on ...

As US’ dependence on Indian pharma is high, thanks to low-cost generic drugs, any tariff hike may not reduce demand ...

WASHINGTON (Reuters) -U.S. President Donald Trump said on Monday that he expects to impose tariffs on imported pharmaceuticals in the not-too-distant future.

Donald Trump confirmed the move, telling reporters on Monday night (local time) he “has a timeline” for levies on foreign pharmaceuticals, which would come in the “not too distant future”.

Watch: Trump namechecks Ireland and says pharma tariffs coming ‘in not too distant future’ The president said he wants to see the US produce its own drugs and added that “all I have to do is impose a ...

Theratechnologies is clearly hot property. The HIV-focused biopharma has received its latest bid from CDMO Future Pak for a cool $255 million—but the drugmaker is already in negotiations with ...